Marques de Valdecilla University Hospital (HUMV)
Santander 39008
0 studies enrolling now · 2 studies all time
What they study most
Metastatic Castration Resistant Prostate Cancer
Studies at this site
- A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
- A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed